SEC Form 4 · accession 0001127602-17-022067
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Davide Molho
Officer — Corporate Executive VP
Period of report
Jun 22, 2017
Accepted (ET)
Jun 23, 2017 · 10:39 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2017 | M | 10,948 | $59.41 | A | 27,497 | D | |
| Common Stock | Jun 22, 2017 | S | 10,948 | $100.00 | D | 16,549 | D | |
| Common Stock | holding | — | — | — | 47,017 | I | By Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $59.41 | Jun 22, 2017 | M | 10,948 | D | Feb 28, 2015 | Feb 28, 2021 | Common Stock | 10,948 | 5,474 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.